Investing.com - Mirum Pharmaceuticals reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Mirum Pharmaceuticals announced earnings per share of $-1.02 on revenue of $18.78M. Analysts polled by Investing.com EPS of $-1.05 on revenue of $20.32M.
Mirum Pharmaceuticals 's are down 0.45% and is trading at $20.17 , still down 33.97% from its 52 week high of $30.55 set on Monday, August 8, 2022.
Mirum Pharmaceuticals shares lost 15.75% to trade at $20.17 in intra-day trade the report.
Mirum Pharmaceuticals follows other major Healthcare sector earnings this month
Mirum Pharmaceuticals's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar